Perspectives On The News, June, 2008: Cardiovascular Disease in Diabetes

POST-TEST QUESTIONS

1. True or False: The diabetic patient without known CVD has virtually the same risk of a CVD event as a non-diabetic patient with known CVD.
  1. True
  2. False

2. True or False: Non-invasive screening studies of the diabetic patient without known CVD show evidence of CAD in at least half of patients studied.

  1. True
  2. False

3. Non-invasive screening studies are recommended for diabetic patient with:

  1. typical or atypical symptoms
  2. an abnormal resting electrocardiogram
  3. no symptoms but with two or more risk factors such as hypertension and dyslipidemia
  4. all of the above
  5. ‘a’ and ‘b’ only

 

4. True or False: Using coronary artery calcium measurement as a screening tool has been shown to improve CV outcome in diabetic patients.

  1. True
  2. False


5. The evidence of an association between lower glucose levels and lower levels of CVD is:

  1. Strong
  2. Weak but suggests a correlation
  3. Not clearly defined

 

6:  True or False: Glucose-lowering treatments always lead to reduction in CVD.

  1. True
  2. False

 

7. In addition to the administration of a statin, current evidence suggests CVD outcome is most likely to be improved by administration of:

  1. A fibrate
  2. Niacin
  3. A bile-acid binding resin
  4. Ezetimibe
  5. An “Omega-3”


8. LDL cholesterol refers to the cholesterol mass within LDL and IDL particles, and non-HDL cholesterol to the cholesterol mass within all apoB-containing particles. The serum apolipoprotein B is a measure of:

  1. the number of atherosclerotic lipoprotein particles
  2. the specific mass of non-HDL
  3. the relative prevalence of small, dense LDL particles

9.  True or False: Studies in which both LDL cholesterol and apoB are compared suggest that LDL cholesterol should remain the primary risk measure and the primary outcome target for persons with diabetes, although apoB may add some further information pertaining to CVD risk.

  1. True
  2. False


10. Antiplatelet treatment has been of great importance for stroke prevention in diabetic patients. Although the greatest number of studies has shown benefit of treatment with aspirin, there is evidence that somewhat greater stroke reduction may be obtained with administration of:

  1. clopidogrel
  2. ticlopidine
  3. the combination of aspirin with dipyramidol
  4. all of the above
  5. “a” and “c”
  6. “b” and “c”